BAV

(redirected from Balloon Aortic Valvuloplasty)
AcronymDefinition
BAVBavaria
BAVBavarian (linguistics)
BAVBioavailability
BAVBase Av
BAVBundesamt für Verkehr (German: Federal Office of Transport; Switzerland)
BAVBicuspid Aortic Valve
BAVBiblioteca Apostolica Vaticana (Italian: Vatican Library)
BAVBrand Asset Valuator
BAVBloc Auriculo-Ventriculaire (French: Atrioventricular Block; cardiology)
BAVBalloon Aortic Valvuloplasty (medical procedure)
BAVBusiness Aviation
BAVBovine Adenovirus
BAVBundesdeutsche Arbeitsgemeinschaft für Veränderliche Sterne (German Workgroup for Variable Stars)
BAVBilim Arastirma Vakfi
BAVBourse aux Vêtements (French: Clothing Exchange)
BAVBoth as View (data integration)
BAVBanna Virus
BAVBay Area Vegetarians
BAVBattle Athletes Victory (anime)
BAVBorn-Again Virgin
BAVBasic Audio Video (product feature)
BAVBritish Airways Virtual
BAVBrouwerij Artikelen Verzamelaars (Dutch)
BAVBuilding Academic Vocabulary
BAVBaarnse Atletiek Vereniging (Dutch)
BAVBeds Available
BAVBateau A Vapeur (French steamship postmark)
BAVBoath Audio Visual (Brighton, UK)
BAVBaotou, PR China (airport code)
BAVBroadcast Area Variable
BAVBiarritz avec Vous (French: Biarritz with You; residential association; Biarritz, French)
References in periodicals archive ?
Five patients underwent transcatheter VSD occlusion, in which four patients had successful device placement and one patient accepted percutaneous balloon aortic valvuloplasty. In brief, all the patients accepted heart catheterization and cardiac angiography with the aim of defining the characteristics of cardiac lesions.
In many institutes, transcatheter balloon aortic valvuloplasty (TBAV) is the first line therapy for neonatal CAS (5).
With rapid ventricular pacing over a long Amplatz extra stiff wire, balloon aortic valvuloplasty using an Edward 4 x 23 mm balloon with simultaneous root aortography to see how the left main flow was performed (Figure 2).
Less invasive methods to replace valves grew from prototype devices designed to prevent regurgitation in the mid-1960s, culminating with the first use of a balloon aortic valvuloplasty in a human with aortic stenosis in 1985.
Surgical aortic valvuloplasty (SAV) and balloon aortic valvuloplasty (BAV) for congenital critical aortic stenosis have near similar outcomes13.
Manta is a novel CE Marked vascular closure device designed to close punctures ranging from 10F to 24F at femoral arterial access sites after cardiac catheterisation procedures such as transcatheter aortic valve replacement, endovascular treatment of abdominal aortic aneurysms (AAA/EVAR), ventricular assist, and balloon aortic valvuloplasty.
MANTA is a novel vascular closure device designed to close punctures ranging from 10F to 24F at femoral arterial access sites after cardiac catheterization procedures, including transcatheter aortic valve replacement (TAVR), endovascular treatment of abdominal aortic aneurysms (AAA/EVAR), ventricular assist (VAD), and balloon aortic valvuloplasty (BAV), according to the company.
One developed endocarditis, then underwent balloon aortic valvuloplasty and aortic valve replacement with a mechanical valve 4 months into pregnancy, with subsequent vaginal delivery at 38 weeks.
It involves a balloon aortic valvuloplasty followed by placement of an artificial valve over the native aortic valve.
Manta is a novel vascular closure device designed to close punctures ranging from 10F to 24F at femoral arterial access sites after cardiac catheterisation procedures such as transcatheter aortic valve replacement, endovascular treatment of abdominal aortic aneurysms (AAA/EVAR), ventricular assist, and balloon aortic valvuloplasty.
Manta closes femoral arterial punctures made during cardiac catheterization procedures such as transcatheter aortic valve replacement, balloon aortic valvuloplasty, and the endovascular treatment of abdominal aortic aneurysms.